Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
University of Alabama at Birmingham Identifier:
First received: January 21, 2000
Last updated: April 11, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2001
  Primary Completion Date: June 2001 (Final data collection date for primary outcome measure)